The next day, she presented to the hospital emergency room with general erythroderma, mild burning sensations and a feeling of tightness in the face, and generalized exfoliation on her face and neck.

Ten people developed and recovered from generalized vaccinia, a rash known to occur a week or so after vaccination in otherwise healthy people. People who suffer from progressive vaccinia, ...

ACAM2000 is supplied as a lyophilized powder that requires reconstitution with the packaged diluent. Following reconstitution, each vial has approximately 100 doses of 0.0025mL of live vaccinia virus.

Generalized or widespread vaccinia infection can also occur. Although the heart conditions and vaccinia infection are uncommon, they are potentially deadly. Trending Now: AbbVie snaps up CAR-T ...

$185+ million in incremental orders for ACAM2000® and VIGIV to be delivered in 2024 and 2025GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today ...

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...

Vaccinia Immune Globulin Intravenous(VIGIV) generic is the only known antidote to the complications of vaccination, prescribed for accidental implantation, eczema vaccinatum, generalized vaccinia ...

TNX-801 is structurally closer to 19th century live-virus vaccinia vaccines than 20th century versions. 1-3 Genomic sequencing of archaic smallpox vaccines has shown that vaccines used prior to ...

This includes the previously disclosed U.S. government contract modification to procure ACAM2000 ®, (Smallpox and Mpox (Vaccinia) Vaccine, Live), as well as CNJ-016 ® [Vaccinia Immune Globulin ...

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...

GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...